[go: up one dir, main page]

MX2009010034A - Pirimidodiazepinas sustituidas utiles inhibidores de la plk1. - Google Patents

Pirimidodiazepinas sustituidas utiles inhibidores de la plk1.

Info

Publication number
MX2009010034A
MX2009010034A MX2009010034A MX2009010034A MX2009010034A MX 2009010034 A MX2009010034 A MX 2009010034A MX 2009010034 A MX2009010034 A MX 2009010034A MX 2009010034 A MX2009010034 A MX 2009010034A MX 2009010034 A MX2009010034 A MX 2009010034A
Authority
MX
Mexico
Prior art keywords
useful
pyrimidodiazepines
substituted
compounds
plk1 inhibitors
Prior art date
Application number
MX2009010034A
Other languages
English (en)
Inventor
Peter Michael Wovkulich
Xin-Jie Chu
Jianping Cai
Shaoqing Chen
Kang Le
Kin-Chun Thomas Luk
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39415299&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009010034(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2009010034A publication Critical patent/MX2009010034A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

La presente invención proporciona compuestos inhibidores de la PLK1, de la fórmula (I): (ver fórmula (I)) Son útiles para el tratamiento o control de trastornos de proliferación celular, en particular los trastornos oncológicos. Estos compuestos y las formulaciones que los contienen pueden ser útiles para el tratamiento o control de tumores sólidos, por ejemplo, los tumores de mama, de colon, de pulmón o de próstata y otros trastornos oncológicos, por ejemplo los linfomas no de Hodgkin.
MX2009010034A 2007-03-22 2008-03-11 Pirimidodiazepinas sustituidas utiles inhibidores de la plk1. MX2009010034A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91935807P 2007-03-22 2007-03-22
PCT/EP2008/052847 WO2008113711A1 (en) 2007-03-22 2008-03-11 Substituted pyrimidodiazepines useful as plk1 inhibitors

Publications (1)

Publication Number Publication Date
MX2009010034A true MX2009010034A (es) 2009-10-12

Family

ID=39415299

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009010034A MX2009010034A (es) 2007-03-22 2008-03-11 Pirimidodiazepinas sustituidas utiles inhibidores de la plk1.

Country Status (23)

Country Link
US (1) US7517873B2 (es)
EP (1) EP2139892B1 (es)
JP (1) JP5087640B2 (es)
KR (1) KR101157848B1 (es)
CN (2) CN101636399B (es)
AR (1) AR065794A1 (es)
AT (1) ATE524472T1 (es)
AU (1) AU2008228303B2 (es)
BR (1) BRPI0809088A2 (es)
CA (1) CA2680757A1 (es)
CL (1) CL2008000785A1 (es)
CY (1) CY1112102T1 (es)
DK (1) DK2139892T3 (es)
ES (1) ES2371832T3 (es)
HR (1) HRP20110807T1 (es)
IL (1) IL200617A (es)
MX (1) MX2009010034A (es)
PE (1) PE20120495A1 (es)
PL (1) PL2139892T3 (es)
PT (1) PT2139892E (es)
SI (1) SI2139892T1 (es)
TW (1) TWI363629B (es)
WO (1) WO2008113711A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008287339A1 (en) * 2007-08-15 2009-02-19 Vertex Pharmaceuticals Incorporated 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5H-pyrimido [4, 5-b][1, 4] diazepin-2-ylamino)-3-methoxybenzamide Derivatives as Inhibitors of the Human Protein Kinases PLK1 to PLK4 for the Treatment of Proliferative Diseases
EP2564850B1 (en) 2007-09-25 2014-08-13 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
EP2610256B1 (en) * 2007-09-28 2016-04-27 Cyclacel Limited Pyrimidine derivatives as protein kinase inhibitors
WO2009067547A1 (en) * 2007-11-19 2009-05-28 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
TWI490214B (zh) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途
WO2009153197A1 (en) * 2008-06-18 2009-12-23 F. Hoffmann-La Roche Ag Halo-substituted pyrimidodiazepines as plkl inhibitors
UY32306A (es) 2008-12-09 2010-07-30 Gilead Sciences Inc Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos
JP5908728B2 (ja) 2009-01-06 2016-04-26 ダナ ファーバー キャンサー インスティテュート インコーポレイテッド ピリミド−ジアゼピノンキナーゼ骨格化合物及び疾患を治療する方法
UY32717A (es) 2009-06-17 2011-01-31 Vertex Pharma Inhibidores de la replicación de virus de la gripe
PL2477987T3 (pl) 2009-09-14 2018-06-29 Gilead Sciences, Inc. Modulatory receptorów toll-podobnych
WO2012083117A1 (en) 2010-12-16 2012-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
WO2014145909A2 (en) * 2013-03-15 2014-09-18 Dana-Farber Cancer Institute, Inc. Pyrimido-diazepinone compounds and methods of treating disorders
US9975896B2 (en) 2013-07-25 2018-05-22 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
TWI652014B (zh) * 2013-09-13 2019-03-01 美商艾佛艾姆希公司 雜環取代之雙環唑殺蟲劑
LT3421468T (lt) 2013-11-13 2021-01-11 Vertex Pharmaceuticals Incorporated Gripo virusų replikacijos inhibitorių paruošimo būdai
EP3578554A1 (en) 2013-11-13 2019-12-11 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
CN106029653A (zh) 2014-01-31 2016-10-12 达纳-法伯癌症研究所股份有限公司 二氨基嘧啶苯砜衍生物及其用途
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
SG11201700070QA (en) 2014-07-11 2017-02-27 Gilead Sciences Inc Modulators of toll-like receptors for the treatment of hiv
BR112017002369A2 (pt) 2014-08-08 2017-12-05 Dana Farber Cancer Inst Inc derivados de diazepana e usos dos mesmos
CN115043840A (zh) 2014-09-16 2022-09-13 吉利德科学公司 制备toll样受体调节剂的方法
WO2016044182A1 (en) 2014-09-16 2016-03-24 Gilead Sciences, Inc. Solid forms of a toll-like receptor modulator
JP6857617B2 (ja) 2015-05-13 2021-04-14 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ インフルエンザウイルスの複製の阻害剤
WO2016183116A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
EP3307728A4 (en) 2015-06-12 2019-07-17 Dana Farber Cancer Institute, Inc. COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND CHINESE INHIBITORS
PE20181086A1 (es) 2015-09-11 2018-07-05 Dana Farber Cancer Inst Inc Acetamida tienotrizolodiazepinas y usos de las mismas
RU2750164C2 (ru) 2015-09-11 2021-06-22 Дана-Фарбер Кэнсер Инститьют, Инк. Цианотиенотриазолодиазепины и пути их применения
MX2018006499A (es) 2015-11-25 2018-08-01 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos.
CN109311901A (zh) * 2016-04-07 2019-02-05 达纳-法伯癌症研究所有限公司 嘧啶并-二氮杂卓酮激酶骨架化合物及治疗pi3k介导的病变的方法
US20220378919A1 (en) * 2019-09-27 2022-12-01 Dana-Farber Cancer Institute, Inc. Erk5 degraders as therapeutics in cancer and inflammatory diseases
WO2021194319A1 (en) * 2020-03-27 2021-09-30 Uppthera Vanillin derivative compounds inducing selective degradation of plk1
WO2022145989A1 (ko) * 2020-12-31 2022-07-07 (주) 업테라 선택적 plk1 억제제로서의 피리미도디아제핀 유도체
US11912710B2 (en) * 2021-08-10 2024-02-27 Uppthera, Inc. Substituted pyrimido[4,5-b][1,4]diazepines as PLK1 degradation inducers
GB202313514D0 (en) 2023-09-05 2023-10-18 Cambridge Entpr Ltd Treatment of inflammatory diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02002938A (es) * 1999-09-17 2004-12-06 Abbott Gmbh & Co Kg Inhibidores de cinasa como agentes agentes terapeuticos.
HRP20040213A2 (en) * 2001-09-04 2005-02-28 Boehringer Ingelheim Pharma Gmbh & Co.Kg Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
US7622463B2 (en) * 2006-02-14 2009-11-24 Vertex Pharmaceuticals Incorporated Dihydrodiazepines useful as inhibitors of protein kinases
TW200808325A (en) * 2006-07-06 2008-02-16 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
HRP20110807T1 (hr) 2011-12-31
CA2680757A1 (en) 2008-09-25
AU2008228303A1 (en) 2008-09-25
PE20120495A1 (es) 2012-05-12
PT2139892E (pt) 2011-11-21
CN101636399B (zh) 2012-04-18
HK1139936A1 (en) 2010-09-30
CN102746175A (zh) 2012-10-24
AR065794A1 (es) 2009-07-01
BRPI0809088A2 (pt) 2014-09-09
KR20090119913A (ko) 2009-11-20
US7517873B2 (en) 2009-04-14
WO2008113711A1 (en) 2008-09-25
US20080234255A1 (en) 2008-09-25
IL200617A0 (en) 2010-05-17
IL200617A (en) 2014-02-27
EP2139892B1 (en) 2011-09-14
CN101636399A (zh) 2010-01-27
PL2139892T3 (pl) 2012-03-30
KR101157848B1 (ko) 2012-07-11
TWI363629B (en) 2012-05-11
JP2010521514A (ja) 2010-06-24
EP2139892A1 (en) 2010-01-06
DK2139892T3 (da) 2011-12-12
AU2008228303B2 (en) 2012-04-19
CN102746175B (zh) 2014-01-15
ATE524472T1 (de) 2011-09-15
CY1112102T1 (el) 2015-11-04
JP5087640B2 (ja) 2012-12-05
TW200843781A (en) 2008-11-16
SI2139892T1 (sl) 2011-12-30
CL2008000785A1 (es) 2009-03-27
ES2371832T3 (es) 2012-01-10

Similar Documents

Publication Publication Date Title
MX2009010034A (es) Pirimidodiazepinas sustituidas utiles inhibidores de la plk1.
IL260127B (en) mek inhibitors and methods of using them
UA100007C2 (ru) Гетероциклические ингибиторы мек, их применение и фармацевтическая композиция, которая их содержит
SG164368A1 (en) Treatment of cancer
IL184678A0 (en) Proteasome inhibitors and methods of using the same
UA104849C2 (uk) 4-піразоліл-n-арилпіримідин-2-аміни і 4-піразоліл-n-гетероарилпіримідин-2-аміни як інгібітори кіназ janus
MX2011006959A (es) Compuestos substituidos de 5,6-dihidro-6-fenilbenzo [f] isoquinolina-2-amina.
IL217623A (en) Amino-carbonyl-boron compound is converted
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
SG10201811480WA (en) Therapeutic compounds and compositions
JO3181B1 (ar) مشتقات كمحول ثاني الكيل البايردينيل - أحادي الفينيل كأنزيم ثنائي استرات الفوسفود
PH12013502369A1 (en) Diazacarbazoles and methods of use
MX2010003365A (es) Derivados de tiazol para el tratamiento de cancer.
MX2010003368A (es) Derivados de imidazol.
MX2009013341A (es) Derivados de 6-(pirrolopiridinil)-pirimidinil-2-amina.
MY155719A (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
EA011572B9 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
MX2007008137A (es) Triazoloftalazinas como inhibidores de pde2.
MX2010007543A (es) Inhibidores de iap.
MX2010003563A (es) Inhibidores de proteina cinasa de c-met.
MX2008002104A (es) Derivados de 1-acildihidropirazol.
GB2469980A (en) Novel napthalimide-benzimidazole hybrids as potential antitumour agents and process for the preparation thereof
MX2009012079A (es) Compuestos heterociclicos condensados como inhibidores de proteina cinasas.
PT2121682E (pt) Derivados de 4-(pirrololpiridinil)-pirimidin-2-il-amina

Legal Events

Date Code Title Description
GB Transfer or rights
FG Grant or registration